Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition: the METS-Microbiome study protocol.

Dugas LR, Lie L, Plange-Rhule J, Bedu-Addo K, Bovet P, Lambert EV, Forrester TE, Luke A, Gilbert JA, Layden BT.

BMC Public Health. 2018 Aug 6;18(1):978. doi: 10.1186/s12889-018-5879-6.

2.

Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology.

Priyadarshini M, Kotlo KU, Dudeja PK, Layden BT.

Compr Physiol. 2018 Jun 18;8(3):1091-1115. doi: 10.1002/cphy.c170050.

PMID:
29978895
3.

Risk of amputations associated with SGLT2 inhibitors compared to DPP-4 inhibitors: A propensity-matched cohort study.

Adimadhyam S, Lee TA, Calip GS, Smith Marsh DE, Layden BT, Schumock GT.

Diabetes Obes Metab. 2018 Jul 3. doi: 10.1111/dom.13459. [Epub ahead of print]

PMID:
29971914
4.

Autophagy Differentially Regulates Insulin Production and Insulin Sensitivity.

Yamamoto S, Kuramoto K, Wang N, Situ X, Priyadarshini M, Zhang W, Cordoba-Chacon J, Layden BT, He C.

Cell Rep. 2018 Jun 12;23(11):3286-3299. doi: 10.1016/j.celrep.2018.05.032.

5.

Gut Microbiota: FFAR Reaching Effects on Islets.

Priyadarshini M, Navarro G, Layden BT.

Endocrinology. 2018 Jun 1;159(6):2495-2505. doi: 10.1210/en.2018-00296.

PMID:
29846565
6.

The Association of Dietary Fiber Intake with Cardiometabolic Risk in Four Countries across the Epidemiologic Transition.

Lie L, Brown L, Forrester TE, Plange-Rhule J, Bovet P, Lambert EV, Layden BT, Luke A, Dugas LR.

Nutrients. 2018 May 16;10(5). pii: E628. doi: 10.3390/nu10050628.

7.

Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease.

Barengolts E, Green SJ, Eisenberg Y, Akbar A, Reddivari B, Layden BT, Dugas L, Chlipala G.

PLoS One. 2018 Mar 29;13(3):e0194171. doi: 10.1371/journal.pone.0194171. eCollection 2018.

8.

Inhibition of mTOR complexes protects cancer cells from glutamine starvation induced cell death by restoring Akt stability.

Khan MW, Layden BT, Chakrabarti P.

Biochim Biophys Acta Mol Basis Dis. 2018 Jun;1864(6 Pt A):2040-2052. doi: 10.1016/j.bbadis.2018.03.013. Epub 2018 Mar 17.

PMID:
29555211
9.

Studies on the Tissue Localization of HKDC1, a Putative Novel Fifth Hexokinase, in Humans.

Khan MW, Ding X, Cotler SJ, Clarke M, Layden BT.

J Histochem Cytochem. 2018 May;66(5):385-392. doi: 10.1369/0022155418756849. Epub 2018 Feb 5.

PMID:
29401404
10.

Oxytocin is lower in African American men with diabetes and associates with psycho-social and metabolic health factors.

Eisenberg Y, Dugas LR, Akbar A, Reddivari B, Layden BT, Barengolts E.

PLoS One. 2018 Jan 4;13(1):e0190301. doi: 10.1371/journal.pone.0190301. eCollection 2018.

11.

Homology modeling of FFA2 identifies novel agonists that potentiate insulin secretion.

Villa SR, Mishra RK, Zapater JL, Priyadarshini M, Gilchrist A, Mancebo H, Schiltz GE, Layden BT.

J Investig Med. 2017 Dec;65(8):1116-1124. doi: 10.1136/jim-2017-000523. Epub 2017 Aug 7.

PMID:
28784695
12.

Incretin-Based Therapies: Revisiting Their Mode of Action.

Layden BT, Wicksteed B, Mauvais-Jarvis F.

Endocrinology. 2017 Jun 1;158(6):1560-1563. doi: 10.1210/en.2017-00252. No abstract available.

13.

Continuous Glucose Monitoring: A Perspective on Its Past, Present, and Future Applications for Diabetes Management.

Mariani HS, Layden BT, Aleppo G.

Clin Diabetes. 2017 Jan;35(1):60-65. doi: 10.2337/cd16-0008. No abstract available.

14.

FFA2 Contribution to Gestational Glucose Tolerance Is Not Disrupted by Antibiotics.

Fuller M, Li X, Fisch R, Bughara M, Wicksteed B, Kovatcheva-Datchary P, Layden BT.

PLoS One. 2016 Dec 13;11(12):e0167837. doi: 10.1371/journal.pone.0167837. eCollection 2016.

15.

Extreme Insulin Resistance in Critically Ill Patient With Sepsis.

Illuri VD, Layden BT, Aleppo G.

Clin Diabetes. 2016 Jul;34(3):158-60. doi: 10.2337/diaclin.34.3.158. No abstract available.

16.

HKDC1 Is a Novel Hexokinase Involved in Whole-Body Glucose Use.

Ludvik AE, Pusec CM, Priyadarshini M, Angueira AR, Guo C, Lo A, Hershenhouse KS, Yang GY, Ding X, Reddy TE, Lowe WL Jr, Layden BT.

Endocrinology. 2016 Sep;157(9):3452-61. doi: 10.1210/en.2016-1288. Epub 2016 Jul 26.

17.

Obesity-related metabolite profiles of black women spanning the epidemiologic transition.

Dugas LR, Chorell E, Plange-Rhule J, Lambert EV, Cao G, Cooper RS, Layden BT, Scholten D, Olsson T, Luke A, Goedecke JH.

Metabolomics. 2016 Mar;12(3). pii: 45. Epub 2016 Feb 5.

18.

Long-term activation of PKA in β-cells provides sustained improvement to glucose control, insulin sensitivity and body weight.

Levine JA, Kaihara KA, Layden BT, Wicksteed B.

Islets. 2016 Sep 2;8(5):125-34. doi: 10.1080/19382014.2016.1198457. Epub 2016 Jun 24.

19.

αB-crystallin and HspB2 deficiency is protective from diet-induced glucose intolerance.

Toft DJ, Fuller M, Schipma M, Chen F, Cryns VL, Layden BT.

Genom Data. 2016 May 13;9:10-7. doi: 10.1016/j.gdata.2016.03.010. eCollection 2016 Sep.

20.

Loss of Free Fatty Acid Receptor 2 leads to impaired islet mass and beta cell survival.

Villa SR, Priyadarshini M, Fuller MH, Bhardwaj T, Brodsky MR, Angueira AR, Mosser RE, Carboneau BA, Tersey SA, Mancebo H, Gilchrist A, Mirmira RG, Gannon M, Layden BT.

Sci Rep. 2016 Jun 21;6:28159. doi: 10.1038/srep28159.

Supplemental Content

Loading ...
Support Center